ArticleScientific reports2025
The treatment based on calcineurin inhibitors and their conversion to sirolimus alter the morphology in the rat testis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The effects of three-drug immunosuppressive regimens on the testis are still not fully known. The aim of this study was to evaluate the long-term effects of immunosuppressive protocols based on calcineurin inhibitors (CNIs) and their conversion to monotherapy with sirolimus on morphology, proliferation, and nuclear DNA fragmentation in the male gonad using an experimental model. For 6 months, male Wistar rats were treated with cyclosporin A (CsA), tacrolimus (FK-506), sirolimus (SRL), mycophenolate mofetil (MMF), and prednisone (Pred). The following protocols were used: CMP (CsA, MMF, and Pred), CMP/S (CsA, MMF, and Pred with conversion to SRL), TMP (FK-506, MMF, and Pred), and TMP/S (FK-506, MMF, and Pred with conversion to SRL). Morphological analyses, including morphometric analysis, immunohistochemical evaluation for proliferation (Ki67), and nuclear DNA fragmentation using the terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) method in the testis, were conducted. In the testes of all the experimental groups, disorders in the organization of the seminiferous epithelium, a lower diameter and area of seminiferous tubules, and a lower percentage of Ki67-positive germinal cells than those in the control group were observed. A lower height of the seminiferous epithelium in the CMP, CMP/S and TMP/S groups than in the control group was noted. A higher percentage of TUNEL-positive germinal cells was detected in the CMP and TMP groups. In the groups with conversion to SRL, a lower diameter and area of seminiferous tubules and height of the seminiferous epithelium (TMP/S vs. TMP) and a lower percentage of Ki67- and TUNEL-positive cells (TMP/S vs. TMP; CMP/S vs. CMP) were revealed. The long-term administration of CNIs in multiple regimens can influence the course of spermatogenesis in the testes of rats, which manifests as morphological alterations in the seminiferous epithelium, vascular accumulation of collagen fibres in interstitial tissue, decreased proliferation of germinal cells and increased nuclear DNA fragmentation related to the apoptotic process. The conversion of treatment with CNIs to SRL also had adverse effects on the seminiferous epithelium; however, it had positive antiapoptotic effects. The obtained results may allow for a better understanding of changes in men undergoing immunosuppressive therapy and a preliminary assessment of which drug combination would be most beneficial in specific clinical cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.